My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.

    Fukushima A, Yamaguchi T, Azuma M, Yagita H, Ueno H.

    Br J Ophthalmol. 2006 Aug;90(8):1040-5. Epub 2006 Apr 13.PMID: 16613922 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.

    Invest Ophthalmol Vis Sci. 2006 Feb;47(2):657-63.PMID: 16431965 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.

    Fukushima A, Sumi T, Ishida W, Ojima A, Kajisako M, Koyanagi A, Koyama N, Yagita H.

    Immunol Lett. 2008 Dec 22;121(2):140-7. Epub 2008 Nov 21.PMID: 19027794 [PubMed - indexed for MEDLINE]Related articles

    4.

    Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.

    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yagita H, Ueno H.

    Br J Ophthalmol. 2006 Dec;90(12):1535-41. Epub 2006 Aug 16.PMID: 16914468 [PubMed - indexed for MEDLINE]Related articles

    5.

    CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.

    Sumi T, Ishida W, Ojima A, Kajisako M, Sakanishi T, Yagita H, Fukushima A.

    Immunol Lett. 2008 Aug 15;119(1-2):91-6. Epub 2008 Jun 12.PMID: 18579220 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.

    Sumi T, Ishida W, Mittler RS, Yagita H, Taguchi O, Fukushima A.

    Int Arch Allergy Immunol. 2009;148(4):305-10. Epub 2008 Nov 11.PMID: 19001790 [PubMed - indexed for MEDLINE]Related articles

    7.

    Role of VLA-4 in the development of allergic conjunctivitis in mice.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H.

    Mol Vis. 2006 Apr 7;12:310-7.PMID: 16617298 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.

    Fukushima A, Yamaguchi T, Sumi T, Fukuda K, Kumagai N, Nishida T, Takeuchi M, Taguchi O, Ueno H.

    Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):705-14. Epub 2006 Oct 6.PMID: 17024440 [PubMed - indexed for MEDLINE]Related articles

    9.

    Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.

    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.

    Int Arch Allergy Immunol. 2008;146(1):36-43. Epub 2007 Dec 14.PMID: 18087160 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Liu FT, Ueno H.

    Clin Experiment Ophthalmol. 2006 May-Jun;34(4):347-53.PMID: 16764655 [PubMed - indexed for MEDLINE]Related articles

    11.

    The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.

    Biochem Biophys Res Commun. 2005 Dec 30;338(4):1726-31. Epub 2005 Nov 7.PMID: 16289109 [PubMed - indexed for MEDLINE]Related articles

    12.

    Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.

    Sumi T, Fukushima A, Nishino K, Fukuda K, Kumagai N, Nishida T, Ueno H.

    Cell Biol Int. 2009 Apr;33(4):534-41. Epub 2009 Feb 20.PMID: 19230848 [PubMed - indexed for MEDLINE]Related articles

    13.

    Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.

    Fukushima A, Sumi T, Ishida W, Yamada J, Iwakura Y, Ueno H.

    Int Arch Allergy Immunol. 2008;147(3):206-12. Epub 2008 Jul 2.PMID: 18594150 [PubMed - indexed for MEDLINE]Related articles

    14.

    Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.

    Fukushima A, Ozaki A, Jian Z, Ishida W, Fukata K, Ueno H, Liu FT.

    Curr Eye Res. 2005 Apr;30(4):241-8.PMID: 15823916 [PubMed - indexed for MEDLINE]Related articles

    15.

    Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.

    Sumi T, Ishida W, Okumura K, Yagita H, Fukushima A.

    Br J Ophthalmol. 2009 Jan;93(1):110-5. Epub 2008 Sep 9.PMID: 18782797 [PubMed - indexed for MEDLINE]Related articles

    16.

    The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ozaki A, Ueno H.

    Immunol Lett. 2005 Sep 15;100(2):189-94.PMID: 15919119 [PubMed - indexed for MEDLINE]Related articles

    17.

    Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.

    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Ueno H.

    Int Arch Allergy Immunol. 2007;144(1):79-84. Epub 2007 May 15.PMID: 17505142 [PubMed - indexed for MEDLINE]Related articles

    18.

    Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.

    Sumi T, Fukushima A, Fukuda K, Kumagai N, Nishida T, Yagita H, Ueno H.

    Immunol Lett. 2007 Jan 15;108(1):62-7. Epub 2006 Nov 7.PMID: 17109973 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.

    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H.

    Exp Eye Res. 2006 Feb;82(2):210-8. Epub 2005 Aug 18.PMID: 16102751 [PubMed - indexed for MEDLINE]Related articles

    20.

    Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.

    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.

    Immunol Lett. 2006 Sep 15;107(1):32-40. Epub 2006 Aug 2.PMID: 16930723 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity